Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Prostatype Genomics

1.10 SEK

-2.65 %

Less than 1K followers

PROGEN

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Prostatype Genomics

EV/S

Median 2020-2022

P/B

Median 2020-2025

 
2019202020212022202320242025
Share price (SEK)-745.92466.33115.7624.186.010.30
Shares0.30.30.30.40.512.459.2
Market cap-188.6134.948.511.374.417.8
Enterprise value-174.2115.840.3---
EV/S-255.011,582.459.3---
EV/EBITDA-neg.neg.neg.---
EV/EBIT-neg.neg.neg.---
P/E-neg.neg.neg.neg.neg.neg.
P/B-6.673.761.850.462.220.67
P/S-276.113,488.771.38.3372.129.9
Dividend yield-0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio48.6 %84.0 %89.3 %84.5 %50.1 %79.7 %52.2 %
Gearing ratio80.2 %5.2 %3.5 %3.3 %--20.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.